Aptevo Therapeutics (APVO) said Friday it will conduct a 1-for-37 reverse stock split, effective Tuesday, to help the company meet Nasdaq's minimum bid price requirement of $1 per share.
The split-adjusted shares will begin trading on the Nasdaq Capital Market on Wednesday, the company said.
The reverse stock split will reduce Aptevo's outstanding number of shares to about 500,000 from 18.5 million and adjust outstanding options, warrants, and other securities, the company added.
Aptevo shares dropped about 18% in recent trading.
Price: 0.28, Change: -0.06, Percent Change: -17.67
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。